The Scotts Miracle-Gro Company filings document the formal record for a North American branded consumer lawn and garden company. Recent 8-K disclosures furnish operating results and financial condition, revised historical financial information reflecting Hawthorne as a discontinued operation, and the completed sale of The Hawthorne Gardening Company.
The filing record also covers capital structure and governance matters, including a senior secured credit agreement, shareholder approval of an amended and restated Long-Term Incentive Plan, forms of restricted stock unit, performance unit and stock option awards, and definitive proxy disclosures on annual meeting proposals and executive compensation.
Brian E. Sandoval, a director of The Scotts Miracle-Gro Company (SMG), reported a transaction on 10/01/2025 in which he received 493 common shares. The Form 4 shows the shares were issued as Deferred Stock Units in lieu of a retainer with a stated value of $28,750, and a per-share price of $58.38 is shown for the transaction. After the transaction the reporting person beneficially owned 14,486 shares. The filing was signed on behalf of Mr. Sandoval by an attorney-in-fact on 10/03/2025. The Form 4 indicates this was a single-person filing and lists the respondent's address at the issuer's headquarters in Marysville, Ohio.
Stephen L. Johnson, a director of Scotts Miracle-Gro Co (SMG), received 247 deferred stock units on 10/01/2025 issued in lieu of a retainer at an implied price of $58.38 per share, representing a value of $14,375. After the transaction the reporting person beneficially owned 27,408 common shares. The Form 4 was signed by an attorney-in-fact on 10/03/2025.
The filing shows a non-cash issuance of equity-linked units to a director as compensation rather than an open-market purchase or sale. The report is a routine Section 16 disclosure of a director's remuneration and resulting beneficial ownership level.
James Hagedorn, Chairman & CEO of Scotts Miracle-Gro Co (SMG), reported a transaction on Form 4 showing an acquisition on 09/30/2025 of 41.1015 common shares at a price of $48.66. Following the reported transaction the filing lists 79,911.6198 shares as directly beneficially owned. The Form 4 also discloses indirect holdings of 29,413.378 shares held through a 401(k) plan and 997,910 shares held by Hagedorn Partnership, L.P., of which the reporting person is a general partner. The filing explains the partnership holdings may cause the reporting person to be deemed a beneficial owner of more than 10% of the issuer's common shares. The form is signed by an attorney-in-fact on behalf of the reporting person with a signature date of 10/03/2025.
Christopher J. Hagedorn, Executive Vice President & Chief of Staff of The Scotts Miracle-Gro Company (SMG), reported a transaction dated 09/30/2025 on a Form 4 filed with the SEC. The filing shows an acquisition of 4.4595 common shares at a reported price of $48.66 per share. After the reported transaction, the filing lists 54,066.5295 shares beneficially owned. The Form 4 was signed by an attorney-in-fact and dated 10/03/2025.
SCOTTS MIRACLE-GRO CO (SMG) reporting person Mark J. Scheiwer, identified as EVP, CFO & CAO, reported a transaction on 09/30/2025. The filing shows a non-derivative acquisition recorded at a price of $48.66 and indicates total beneficial ownership following the transaction of 10,136.2655 common shares. The report also discloses 433.874 shares held indirectly through a 401(k) plan. The Form 4 is signed by an attorney-in-fact on behalf of the reporting person.
Christopher J. Hagedorn, EVP & Chief of Staff of The Scotts Miracle-Gro Company (SMG), reported a transaction on 09/05/2025 in the company’s common shares. The Form 4 records a transaction code J with an entry showing 2.6532 (listed under the V column) and a price of $62.5085. Following the reported transaction, the form lists 54,062.07 shares beneficially owned. The filing was signed on behalf of Mr. Hagedorn by an attorney-in-fact on 09/30/2025. No additional explanatory remarks are provided in the form.
Nathan Eric Baxter, President and COO and a director of Scotts Miracle-Gro Company (SMG), filed a Form 4 reporting transactions dated 09/05/2025. The filing shows a non-derivative acquisition with codes listed as J and V, a quantity shown as 19.5915 A at a price of $62.5085. Following the reported transactions the filing shows 50,728.1148 (listed with a “D” in the form) as the amount of securities beneficially owned, and separately discloses 36,993 held indirectly through Hagedorn Partnership, L.P. The form includes an explanatory note that the reporting person may be deemed to beneficially own Partnership-held shares under Rule 16a-1(a)(1). The Form 4 is signed by an attorney-in-fact on 09/30/2025.
The Scotts Miracle-Gro Company (SMG) Form 144 notifies the market of a proposed sale of 11,297 common shares, with an aggregate market value of $681,302.71, intended for sale on the NYSE on or about 09/10/2025. The filing identifies the broker as Merrill and reports total shares outstanding of 57,738,577. The securities to be sold were acquired through restricted stock vesting on various dates between 2019 and 2023 from Scotts Miracle-Gro. The filer reports no securities sold in the past three months and certifies no undisclosed material adverse information.
The Scotts Miracle-Gro Company (SMG) director Austin Scott Miller reported an acquisition of 15 common-share equivalents related to dividend equivalent rights on restricted/share units. The transaction date was 09/05/2025 and the Form 4 was signed on 09/09/2025 by an attorney-in-fact. The filing shows 15 shares acquired at an economic value tied to $63.04 each, and 15 shares beneficially owned following the transaction. The filing clarifies these dividend equivalent rights accrue with DSUs/RSUs and are each economically equivalent to one common share. No other transactions, dispositions, or pledges are disclosed in this filing.
The Scotts Miracle-Gro Company (SMG) director Nick Miaritis reported an acquisition of 32 common shares on 09/05/2025. The shares were issued as dividend equivalent rights tied to DSU/RSU grants and were recorded at a price of $63.04 per share. After this transaction, Mr. Miaritis beneficially owned 93 shares. The filing was signed on behalf of the reporting person by an attorney-in-fact on 09/09/2025. The form notes that dividend equivalents accrue with DSUs/RSUs and are economically equivalent to common shares.